BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7575169)

  • 1. [Atrial fibrillation and Wolff-Parkinson-White syndrome. The hidden danger of manifested pathways].
    Cruz Filho FE
    Arq Bras Cardiol; 1995 Feb; 64(2):97-100. PubMed ID: 7575169
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is the transesophageal approach preferable to endocavitary approach in the evaluation of Wolff-Parkinson-White syndrome?].
    Brembilla-Perrot B; Beurrier D
    Arch Mal Coeur Vaiss; 1995 Mar; 88(3):353-8. PubMed ID: 7487289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in frequency of conduction over accessory atrio-ventricular pathways upon transition from atrial fibrillation to atrial flutter.
    Milan D; Keane D
    Int J Cardiol; 2005 Feb; 98(3):513-5. PubMed ID: 15708191
    [No Abstract]   [Full Text] [Related]  

  • 4. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
    Duckeck W; Kuck KH
    Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Digitalis and atrial fibrillation in 1985].
    Meijler FL; van der Tweel I
    Ned Tijdschr Geneeskd; 1985 Apr; 129(16):729-35. PubMed ID: 3990870
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atrial fibrillation in Wolff-Parkinson-White syndrome in the light of electrophysiologic studies. IV].
    Musiał WJ
    Kardiol Pol; 1985; 28(12):767-75. PubMed ID: 3835377
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrophysiologic effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation].
    Chimienti M; Moizi M; Salerno JA; Klersy C; Marangoni E; Previtali M; Montemartini C; Bobba P
    Cardiologia; 1986 Feb; 31(2):155-61. PubMed ID: 3098424
    [No Abstract]   [Full Text] [Related]  

  • 8. Atrial vulnerability is a major mechanism of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
    Zhang Y; Wang L
    Med Hypotheses; 2006; 67(6):1345-7. PubMed ID: 16697118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preexcitation syndrome.
    Sung RJ; Castellanos A
    Cardiovasc Clin; 1980; 11(1):103-12. PubMed ID: 7438142
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concealed preexcitation].
    Krikler D
    Coeur Med Interne; 1978; 17(1):3-5. PubMed ID: 639487
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome].
    Tsuchioka Y; Yamaoka K; Yamamoto M; Sueda T; Kanazawa I; Yuasa A; Eno S; Matsuura H; Kurogane H; Tateishi H
    Kokyu To Junkan; 1984 Aug; 32(8):829-33. PubMed ID: 6515138
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac vulnerability.
    Surawicz B; Steffens T
    Cardiovasc Clin; 1973; 5(3):159-81. PubMed ID: 4601967
    [No Abstract]   [Full Text] [Related]  

  • 13. Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Varriale P; Sedighi A; Mirzaietehrane M
    Pacing Clin Electrophysiol; 1999 Aug; 22(8):1267-9. PubMed ID: 10461309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmias in Wolff-Parkinson-White syndrome].
    Dabrowski A
    Kardiol Pol; 1976; 19(5):395-401. PubMed ID: 994367
    [No Abstract]   [Full Text] [Related]  

  • 15. Supernormal conduction in the anomalous bundles of the Wolff-Parkinson-White syndrome: an overlooked electrophysiologic property with potential clinical implications.
    Chiale PA; Albino E; Garro HA; Selva H; Levi RJ; Sánchez RA; Elizari MV; Alvarez CB
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):181-91. PubMed ID: 17875945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation triggered by postinfarction ventricular premature beats in a patient with Wolff-Parkinson-White syndrome.
    Peinado R; Merino JL; Gnoatto M; Arias MA
    Europace; 2005 May; 7(3):221-4. PubMed ID: 15878558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachyarrhythmias related to Wolff-Parkinson-White syndrome.
    Chung EK
    Heart Lung; 1977; 6(2):262-8. PubMed ID: 584716
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.
    Niwano S; Kitano Y; Moriguchi M; Izumi T
    Heart; 2000 May; 83(5):E8. PubMed ID: 10768920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patent and occult Wolff-Parkinson-White syndrome. Electrophysiological studies].
    Portillo B; León N; Portillo N; Barboza A; Gerka C
    Bol Asoc Med P R; 1981 Dec; 73(12):606-32. PubMed ID: 6952882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outcome of Wolff-Parkinson-White syndrome in children. Transesophageal study of anterograde permeability of the accessory pathway and of atrial vulnerability].
    Villain E; Attali T; Iserin L; Aggoun Y; Kachaner J
    Arch Mal Coeur Vaiss; 1994 May; 87(5):649-52. PubMed ID: 7857188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.